848821-06-7 Usage
Uses
Used in Pharmaceutical Industry:
4-CYANO-TETRAHYDROPYRAN-4-CARBOXYLIC ACID is used as a building block for the development of drugs and active pharmaceutical ingredients. Its presence of a cyano group and carboxylic acid functional group allows for versatile chemical modifications, making it a valuable component in the synthesis of various medicinal compounds.
Used in Organic Synthesis:
In the field of organic synthesis, 4-CYANO-TETRAHYDROPYRAN-4-CARBOXYLIC ACID is used as an intermediate for the synthesis of complex organic molecules. Its unique structure and functional groups facilitate the formation of new chemical entities, contributing to the advancement of organic chemistry.
Used in Materials Science:
4-CYANO-TETRAHYDROPYRAN-4-CARBOXYLIC ACID may also find applications in materials science, where its structural properties could be utilized to create new materials with specific characteristics. The exact applications in this field are still under investigation, highlighting the need for further research to explore its full potential.
As the properties and uses of 4-cyano-THP-4-carboxylic acid are still being studied, ongoing research is essential to fully understand and harness its potential applications across various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 848821-06-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,8,2 and 1 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 848821-06:
(8*8)+(7*4)+(6*8)+(5*8)+(4*2)+(3*1)+(2*0)+(1*6)=197
197 % 10 = 7
So 848821-06-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H9NO3/c8-5-7(6(9)10)1-3-11-4-2-7/h1-4H2,(H,9,10)
848821-06-7Relevant academic research and scientific papers
IMIDAZO[1,2-A]PYRIDINYL DERIVATIVES AS IRAK4 INHIBITORS
-
, (2022/03/31)
This invention relates to Imidazo[1,2-a]pyridinyl Derivatives of formula (I′), or pharmaceutically acceptable salts thereof, in which all of the variables are as defined in the specification, capable of modulating the activity of IRAK4. The invention further provides a method of manufacturing compounds of the invention, and methods for their therapeutic use. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including inflammatory disease, autoimmune disease, cancer, cardiovascular disease, a disease of the central nervous system, disease of the skin, an ophthalmic disease and condition, and a bone disease.
PROCESS FOR THE PREPARATION OF VENETOCLAX
-
Page/Page column 29; 30, (2018/03/06)
The present disclosure provides novel synthetic process for the preparation of venetoclax. The disclosed processes involve the use of novel intermediates. Processes for the preparation of these intermediates are also disclosed as well as methods for the preparation of particularly useful salts thereof.
